[
  {
    "ts": null,
    "headline": "Insulet Corporation (PODD): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD. Insulet Corporation’s share was trading at $255.81 as of January 30st. PODD’s trailing and forward P/E were 74.37 and 41.84 respectively according to Yahoo Finance. Insulet Corporation develops, manufactures, and sells insulin delivery […]",
    "url": "https://finnhub.io/api/news?id=c9310f26628ff1c25fe4c1cb49cc2a3aaa111b926c6e7e3e01d43a6d0e7cc627",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770079852,
      "headline": "Insulet Corporation (PODD): A Bull Case Theory",
      "id": 138338108,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD. Insulet Corporation’s share was trading at $255.81 as of January 30st. PODD’s trailing and forward P/E were 74.37 and 41.84 respectively according to Yahoo Finance. Insulet Corporation develops, manufactures, and sells insulin delivery […]",
      "url": "https://finnhub.io/api/news?id=c9310f26628ff1c25fe4c1cb49cc2a3aaa111b926c6e7e3e01d43a6d0e7cc627"
    }
  }
]